Celularity, Inc. (CELU)
1.60
+0.22
(+15.94%)
USD |
NASDAQ |
Oct 02, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Celularity Profit Margin (Quarterly) : 17.55% for March 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 17.55% |
| December 31, 2025 | -593.6% |
| September 30, 2025 | -436.7% |
| June 30, 2025 | -427.5% |
| March 31, 2025 | -173.4% |
| December 31, 2024 | -73.31% |
| September 30, 2024 | -173.2% |
| June 30, 2024 | -53.57% |
| March 31, 2024 | -149.9% |
| December 31, 2023 | 78.82% |
| September 30, 2023 | -2.48K% |
| June 30, 2023 | -1.63K% |
| Date | Value |
|---|---|
| March 31, 2023 | -1.63K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -83.16% |
| September 30, 2021 | |
| June 30, 2021 | -2.02K% |
| March 31, 2021 | -3.07K% |
| December 31, 2020 | |
| September 30, 2020 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.44K% |
| Cardio Diagnostics Holdings, Inc. | -27.81K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -46.55% |
| Return on Invested Capital | -158.4% |
| Gross Profit Margin (Quarterly) | 20.70% |
| Operating Margin (Quarterly) | -263.5% |
| Return on Net Operating Assets | -69.72% |